Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

episode

Breast Cancer Update not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Episode 180 - Daria Dawson 1h 34m · 18 Sep 2026 · Grits and Eggs Podcast

NPR News: 09-18-2026 5AM EDT 5 min · 18 Sep 2026 · NPR News Now

SYSK Gets Weird Playlist: What is Collective Hysteria? 51 min · 18 Sep 2026 · Stuff You Should Know

The legacy of silence - Ireland's magdalene laundries and mother & baby homes 11 min · 18 Sep 2026 · Today with David McCullagh

5AM ET 09/18/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded01 Nov 2024

Publisherfeeds.captivate.fm ↗

Handlerec:5010169

Show notes

Prof Francois-Clement Bidard from Institut Curie in Paris and Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta discuss improving the outcomes of first-line endocrine-based therapy for patients with HR-positive, HER2-negative metastatic breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related